Newcleo PLC Reports Q3 Revenue Growth and Increased Cash Reserves
Newcleo PLC (NWCL) has reported its third-quarter financial results, highlighted by a significant revenue increase of approximately 26% compared to the same period in the previous year. The company reached $10 billion in revenue for the quarter ended September 30, 2025. The company also demonstrated improved liquidity, reporting cash and cash equivalents of €233.4 million as of September 30, 2026, a substantial rise from €90.4 million in the prior year's period. Additionally, capital expenditures saw a slight reduction to approximately €11.3 million compared to €12.9 million in the previous year.

Tickers: $NWCL
Topics: capital expenditure cash flow quarterly earnings revenue growth
Read the full article at Seeking Alpha
Part of the story Aktis Oncology Reports Q3 Revenue Growth and Significant Increase in Cash Reserves (3 articles)